For Young Adults Addicted To Opioids, New Training Approach Launched By NIDA Blending Conference

A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled at the National Institute on Drug Abuse’s (NIDA) Blending Conference in Albuquerque, N.M. This eighth meeting in the series briought together researchers and clinicians so their latest findings could be immediately applied to the needs of patients and their families dealing with addictive disorders. NIDA is a component of the National Institutes of Health.

The new treatment product, Buprenorphine Treatment for Young Adults, was based on research by NIDA’s Clinical Trials Network in partnership with the Substance Abuse and Mental Health Services Administration (SAMHSA). It showed that young adults given longer term treatment with the medication buprenorphine were less likely to use drugs and more likely to stay in treatment, compared to those who received short term detoxification without follow-up medication. Buprenorphine helps relieve drug cravings.

“Buprenorphine had been proven effective with adults, but until recently, evidence was lacking that its anti-addiction properties would work in this important group of younger patients,” said NIDA Director Dr. Nora Volkow. “The new product includes a three-hour training package that examines opioid use among young adults and looks at research results showing the effectiveness of buprenorphine for this age group.”

The training program is in a suite of buprenorphine products developed by the Blending Initiative. Among them: training for addiction professionals about laws governing the office-based use of the treatment; a discussion of how to select appropriate patients; and an explanation of how buprenorphine works. Yet another product outlines the results of a NIDA clinical trial comparing short-term detoxification with buprenorphine versus clonidine, another addiction treatment.

This spring’s conference was titled “Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings.” In addition to the new buprenorphine products, the topics ranged from controlling heroin and opioid addiction in young adults to understanding genetic changes in the brain that underlie addiction.

“Rapid advances in our understanding of the mechanisms behind addiction have expanded our treatment horizon dramatically in recent years,” said Dr. Volkow. “The value of the Blending Conference is that it provides an opportunity to translate basic research knowledge into everyday clinical practice.”

The Albuquerque conference is the biggest Blending meeting to date, with more than 1,300 registrants. Those attending included leading addiction treatment specialists, health care providers, criminal justice professionals, researchers and policymakers.

Other sessions included:

Developing new drug addiction treatments: Dr. Volkow highlighted the dramatic scientific advances that help explain the molecular and genetic changes that underlie addiction.
Vaccines for treating nicotine and cocaine addiction: Could the immune system be exploited to help smokers quit or cocaine users from relapsing? The idea is that by evoking an immune/antibody response to nicotine, we could keep it out of the brain, blocking its rewarding effects and promoting abstinence. A similar approach is being used with cocaine. Clinical trials are underway.
A special track addressing American Indian and Alaskan Natives: These populations have long endured historical trauma and discrimination that have contributed to negative health outcomes, including substance abuse and HIV infection. Presenters will discuss how a culturally appropriate treatment framework based on input from the Native American community can respond to these complex health issues.
Veterans with post traumatic stress disorder (PTSD): In the aftermath of combat stress, soldiers can develop mental health and substance abuse problems which can spill over into the family environment with destructive consequences. Addiction scientists will discuss the complex effects of combat-related PTSD on veterans, reservists and their families.

Source:
NIDA Press Office
NIH/National Institute on Drug Abuse

More Treatment & Detox Articles

Study says parents shouldn’t drink with their teens

It’s not uncommon for parents to serve their teenagers alcohol as a way to teach responsible drinking habits. While attending Los Gatos high school in the South Bay, I experienced this first hand, going to many keg parties where a parent was filling the plastic cups with Coors Light. Usually, the parents felt it was….

Alcohol in new Zealand

Alcohol has been excessively commercialised, over-hyped and over-sold. It is treated in the market place as if it were just an ordinary grocery item when, in fact, it is a highly intoxicating recreational drug, argues Doug Sellman. There is little doubt that New Zealand has a serious alcohol problem. Every day we are presented with….

What you Can’t Bring to Treatment

Are you heading into a treatment program to get help for a drug or alcohol addiction? If you’re already on your way to getting the help you need and you’re trying to figure out what it is that you should (or should not) bring with you to drug or alcohol addiction treatment, consider these items….

Top 10 Signs of Addiction

Are you concerned that a loved one is addicted to drugs and/or alcohol? If so, you must know the signs and symptoms of addiction, as this will allow you to pinpoint the problem and eventually get this person the help he or she needs. Some signs of addiction are easy to see, while others can….

Signs and Symptoms of alcohol addiction

Alcohol addiction is a problem largely related to the physiological dependency of a person on alcohol. Therefore, getting rid of the alcohol addiction is not a simple task. Sudden withdrawal from alcohol can be very unpleasant for the addict and can lead to medical consequences, therefore, proper methods needs to be adopted when treating alcohol….